%0 Journal Article %J J Alzheimers Dis %D 2019 %T Sirtuin 3 Mediates Tau Deacetylation. %A Li, Shiping %A Yin, Junxiang %A Nielsen, Megan %A Beach, Thomas G %A Guo, Li %A Shi, Jiong %X

BACKGROUND: Emerging evidence shows tau acetylation has been observed in Alzheimer's disease (AD) brain at early Braak stages and is involved in regulating tau early accumulation. However, the effects of deacetylase Sirtuin 3 (Sirt3) on tau acetylation and its aggregations are unclear.

OBJECTIVE: We studied the effects of Sirt3 on tau acetylation and its aggregations.

METHODS: We investigated the protein levels of Sirt3 and tangle tau in human postmortem brains slices from AD, mild cognitive impairment, and age- and education-matched cognitively normal subjects, and AD model mice. We also measured tau acetylation levels in hippocampal HT22 cells after Sirt3 knockdown or overexpression.

RESULTS: The level of Sirt3 was inversely related with tau protein in brain slices from both human being and AD model mice. Mechanistically, tau acetylation decreased dramatically with Sirt3 overexpression, while tau acetylation increased after Sirt3 knockdown in hippocampal HT22 cells.

CONCLUSIONS: Sirt3 may play a role in tau acetylation and could be a potential target for novel therapy to alleviate tau accumulation.

%B J Alzheimers Dis %V 69 %P 355-362 %8 2019 May 21 %G eng %N 2 %R 10.3233/JAD-190014